Association of Morbid Progression With Overall Survival Among Patients With Multiple Myeloma: Validation of the Progression-free Survival Endpoint-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of Morbid Progression With Overall Survival Among Patients With Multiple Myeloma: Validation of the Progression-free Survival Endpoint

Published:2021-05 Issue:5 Volume:21 Page:345-354.e4
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Rosenberg Aaron S.,Facon Thierry,Parikh Kejal,Chung Weiyuan,Srinivasan Shankar,Kotey Stanley,Tuscano Joseph

Funder

Celgene

National Cancer Institute

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference19 articles.

1. Multiple myeloma: diagnosis and treatment;Rajkumar;Mayo Clin Proc,2016

2. Multiple myeloma: is it time for biomarker-driven therapy?;Bhutani;Am Soc Clin Oncol Educ Book,2015

3. Treatment of relapsed and refractory multiple myeloma;Sonneveld;Haematologica,2016

4. International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma;Rajkumar;Lancet Oncol,2014

5. Evolving diagnostic criteria for multiple myeloma;Rajkumar;Hematology Am Soc Hematol Educ Program,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes after biochemical or clinical progression in patients with multiple myeloma;Blood Advances;2023-03-15

2. Time‐to‐event surrogate end‐points in multiple myeloma randomised trials from 2005 to 2019: A surrogacy analysis;British Journal of Haematology;2022-12-10

3. Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee;Blood Cancer Journal;2022-06-29

4. How do we manage t(11;14) plasma cell disorders with venetoclax?;British Journal of Haematology;2022-05-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3